![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Sun Pharma Receives FDA OK to Make Generic Uroxatral
Sun Pharma Receives FDA OK to Make Generic Uroxatral
August 5, 2011
The FDA has approved Sun Pharmaceutical’s ANDA for a generic version of Sanofi’s prostate treatment Uroxatral XR, giving Sun 180 days of marketing exclusivity as the first filer.
Generic Line
Generic Line
Upcoming Events
-
21Oct